Literature DB >> 12124346

Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.

Marion P Butler1, Shinsuke Iida, Daniela Capello, Davide Rossi, Pulivarthi H Rao, Palanisamy Nallasivam, Diane C Louie, Seeta Chaganti, Thomas Au, Randy D Gascoyne, Gianluca Gaidano, Raju S K Chaganti, Riccardo Dalla-Favera.   

Abstract

Chromosomal translocations involving band 3q27 with various different partner chromosomes represent a recurrent cytogenetic abnormality in B-cell non-Hodgkin's lymphoma. In a fraction of these translocations, the chromosomal breakpoint is located within the 5' noncoding region of the BCL-6 proto-oncogene where the BCL-6 major breakpoint region (MBR) maps. As a result of the translocation, BCL-6 expression is deregulated by promoter substitution. However, between 30 and 50% of lymphomas with cytogenetically detectable translocations affecting band 3q27 retain a germ-line configuration at the BCL-6 locus. To identify possible additional breakpoint clusters within 3q27, we cloned a t(3;14)(q27;q32) lymphoma without MBR rearrangement and found a novel breakpoint site located between 245 and 285 kb 5' to BCL-6. Breakpoints within this newly described region, which we called the alternative breakpoint region (ABR), were found to be recurrent in lymphomas carrying t(3q27) chromosomal translocations but devoid of BCL-6 MBR rearrangements. Comparative analysis of multiple lymphomas carrying rearrangements within the ABR showed that the breakpoints cluster within a 20-kb distance. Translocations involving the ABR may juxtapose BCL-6 to distantly acting, heterologous transcriptional regulatory elements which cause deregulation of the proto-oncogene. The identification of BCL-6 ABR provides new tools for the diagnosis of lymphomas carrying aberrations at 3q27 and deregulated BCL-6 genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124346

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma.

Authors:  Murali Janakiram; Venu K Thirukonda; Matthew Sullivan; Adam M Petrich
Journal:  Curr Treat Options Oncol       Date:  2012-02-02

2.  BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells.

Authors:  Himabindu Ramachandrareddy; Alyssa Bouska; Yulei Shen; Ming Ji; Angie Rizzino; Wing C Chan; Timothy W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

Review 3.  Pathogenesis of diffuse large B cell lymphoma.

Authors:  Wing John C Chan
Journal:  Int J Hematol       Date:  2010-06-29       Impact factor: 2.490

4.  Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.

Authors:  Katia Basso; Masumichi Saito; Pavel Sumazin; Adam A Margolin; Kai Wang; Wei-Keat Lim; Yukiko Kitagawa; Christof Schneider; Mariano J Alvarez; Andrea Califano; Riccardo Dalla-Favera
Journal:  Blood       Date:  2009-12-03       Impact factor: 22.113

5.  Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.

Authors:  Jun Hyun Kim; Alexander V Penson; Barry S Taylor; John H J Petrini
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-08       Impact factor: 11.205

6.  Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.

Authors:  Yoshitsugu Mitani; Pulivarthi H Rao; P Andrew Futreal; Dianna B Roberts; Philip J Stephens; Yi-Jue Zhao; Li Zhang; Mutsumi Mitani; Randal S Weber; Scott M Lippman; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

7.  Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.

Authors:  Russell J H Ryan; Yotam Drier; Holly Whitton; M Joel Cotton; Jasleen Kaur; Robbyn Issner; Shawn Gillespie; Charles B Epstein; Valentina Nardi; Aliyah R Sohani; Ephraim P Hochberg; Bradley E Bernstein
Journal:  Cancer Discov       Date:  2015-07-30       Impact factor: 39.397

8.  Human and mouse genomic sequences reveal extensive breakpoint reuse in mammalian evolution.

Authors:  Pavel Pevzner; Glenn Tesler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

9.  t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.

Authors:  Keni Gu; Kai Fu; Smrati Jain; Zhongfen Liu; Javeed Iqbal; Min Li; Warren G Sanger; Dennis D Weisenburger; Timothy C Greiner; Patricia Aoun; Bhavana J Dave; Wing C Chan
Journal:  Mod Pathol       Date:  2009-05-22       Impact factor: 7.842

10.  BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells.

Authors:  Huifeng Niu; Giorgio Cattoretti; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2003-07-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.